Treatment of Pyoderma Gangrenosum With Granulocyte and Monocyte Adsorption Apheresis
- 1 August 2005
- journal article
- case report
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 9 (4), 292-296
- https://doi.org/10.1111/j.1744-9987.2005.00284.x
Abstract
Pyoderma gangrenosum is an intractable skin disorder characterized by the development of erythematous pustules or nodules that rapidly progress to destructive, necrotizing, non-infective ulcers. We assessed the efficacy of granulocyte and monocyte adsorption apheresis (GCAP) therapy in two new patients, a 67-year-old man with ulcerations on his lower leg, and a 44-year-old man with turgid erythematous lesions with burrowing abscesses and sinus formation on his hip, groin, and thighs. Both patients received 10 GCAP treatments at 5-day intervals. Their skin lesions responded well. The 9 cmx6 cm ulcer on the lower right leg of the 67-year-old patient was completely covered by regenerated skin at the completion of therapy. The turgid skin lesions containing pustules and ulcers of the other patient showed amelioration and a marked decrease in the volume of exudate. Our results suggest that GCAP is a useful treatment modality for pyoderma gangrenosum.Keywords
This publication has 14 references indexed in Scilit:
- Treatment of behçet's disease with granulocyte and monocyte adsorption apheresisJournal of the American Academy of Dermatology, 2004
- Improvement of adult Still's disease with granulocyte and monocyte adsorption apheresisClinical and Experimental Dermatology, 2004
- Treatment of psoriatic arthritis with granulocyte and monocyte adsorption apheresisJournal of the American Academy of Dermatology, 2004
- Improvement of SLE Skin Rash with Granulocyte and Monocyte Adsorption ApheresisDermatology, 2004
- Adacolumn, an Adsorptive Carrier Based Granulocyte and MonocyteApheresis Device for the Treatment of Inflammatory and RefractoryDiseases Associated with LeukocytesTherapeutic Apheresis and Dialysis, 2003
- Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: A prospective, uncontrolled, pilot studyClinical Gastroenterology and Hepatology, 2003
- Pyoderma gangrenosumThe Lancet, 1998
- Human leukocyte elastase is an endogenous ligand for the integrin CR3 (CD11b/CD18, Mac-1, alpha M beta 2) and modulates polymorphonuclear leukocyte adhesion.The Journal of Experimental Medicine, 1996
- Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel diseaseThe Esophagus, 1995
- A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen.The Journal of cell biology, 1993